Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
Abstract Objectives The objective of this study is to investigate the association between the use of beta‐adrenergic antagonist atenolol and risk of pathologic upgrade in patients on active surveillance, considering growing literature implicating adrenergic innervation with disease progression media...
Saved in:
Main Authors: | Ali H. Zahalka, Ethan Fram, Evan Garden, Lauren Howard, Emily Wiggins, Mustufa Babar, Jay Annam, Allison Reagan, Benjamin Eilender, Amanda deHoedt, Stephen J. Freedland, Ash Tewari, Kara L. Watts |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-11-01
|
Series: | BJUI Compass |
Subjects: | |
Online Access: | https://doi.org/10.1002/bco2.441 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01) -
Scrutinizing the evidence of anthracene toxicity on adrenergic receptor beta-2 and its bioremediation by fungal manganese peroxidase via in silico approaches
by: Muhammad Naveed, et al.
Published: (2025-01-01) -
The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes
by: Sabine Werner, et al.
Published: (2020-06-01) -
Microextraction-Based Techniques for the Determination of Beta-Blockers in Biological Fluids: A Review
by: Styliani Nisyriou, et al.
Published: (2025-01-01) -
Disorders of the central nervous system cognitive and mnestic functions in genetic arterial hypertension and with the use of beta-blockers of different generations
by: A. O. Svitlytskyi, et al.
Published: (2024-09-01)